Protective Factors for Colorectal Cancer
Main Article Content
Abstract
Article Details
This work is licensed under a Creative Commons Attribution 4.0 International License.
References
REFERENCES
I. Qadir, M. I., & Ghalia, B. A. (2018). Awareness survey about colorectal cancer in students of M. Phil Biotechnology at Bahauddin Zakariya University, Multan, Pakistan. Nov Appro in Can Study, 1(3).
II. Macrae, F. A., Goldberg, R. M., & Seres, D. (2016). Colorectal cancer: Epidemiology, risk factors, and protective factors. Uptodate com [ažurirano 9. lipnja 2017.
III. Kotzev, I., Mirchev, M., Manevska, B., Ivanova, I., & Kaneva, M. (2008). Risk and protective factors for development of colorectal polyps and cancer. Hepato Gastroenterol, 55, 381-387.
IV. Castro-Rodriguez, J. A., Garcia-Marcos, L., Rojas, J. D. A., Valverde-Molina, J., & Sanchez-Solis, M. (2008). Mediterranean diet as a protective factor for wheezing in preschool children. The Journal of pediatrics, 152(6), 823-828.
V. Segovia-Siapco, G., & Sabaté, J. (2019). Health and sustainability outcomes of vegetarian dietary patterns: a revisit of the EPIC-Oxford and the Adventist Health Study-2 cohorts. European journal of clinical nutrition, 72(1), 60-70.
VI. Park, Y., Hunter, D. J., Spiegelman, D., Bergkvist, L., Berrino, F., Van Den Brandt, P. A., ... & Smith-Warner, S. A. (2005). Dietary fiber intake and risk of colorectal cancer: a pooled analysis of prospective cohort studies. Jama, 294(22), 2849-2857.
VII. Mathers, J. C., Movahedi, M., Macrae, F., Mecklin, J. P., Moeslein, G., Olschwang, S., ... & CAPP2 Investigators. (2012). Long-term effect of resistant starch on cancer risk in carriers of hereditary colorectal cancer: an analysis from the CAPP2 randomised controlled trial. The lancet oncology, 13(12), 1242-1249.
VIII. Moazzen, S., Dolatkhah, R., Tabrizi, J. S., Shaarbafi, J., Alizadeh, B. Z., de Bock, G. H., & Dastgiri, S. (2018). Folic acid intake and folate status and colorectal cancer risk: a systematic review and meta-analysis. Clinical nutrition, 37(6), 1926-1934.
IX. Zhang, X. H., Ma, J., Smith-Warner, S. A., Lee, J. E., & Giovannucci, E. (2013). Vitamin B6 and colorectal cancer: current evidence and future directions. World journal of gastroenterology: WJG, 19(7), 1005.
X. Ortega, R. M., Ortega, A. I. J., Sánchez, J. M. P., Soto, E. C., Vizuete, A. A., & López-Sobaler, A. M. (2019). Nutritional value of dairy products and recommended daily consumption. Nutricion hospitalaria, 36(Spec No3), 25-29.
XI. Gorham, E. D., Garland, C. F., Garland, F. C., Grant, W. B., Mohr, S. B., Lipkin, M., ... & Holick, M. F. (2005). Vitamin D and prevention of colorectal cancer. The Journal of steroid biochemistry and molecular biology, 97(1-2), 179-194.
XII. Chen, G. C., Pang, Z., & Liu, Q. F. (2012). Magnesium intake and risk of colorectal cancer: a meta-analysis of prospective studies. European journal of clinical nutrition, 66(11), 1182-1186.
XIII. Ngo, S. N., Williams, D. B., Cobiac, L., & Head, R. J. (2007). Does garlic reduce risk of colorectal cancer? A systematic review. The Journal of nutrition, 137(10), 2264-2269.
XIV. Wu, S., Feng, B., Li, K., Zhu, X., Liang, S., Liu, X., ... & Fan, D. (2012). Fish consumption and colorectal cancer risk in humans: a systematic review and meta-analysis. The American journal of medicine, 125(6), 551-559.
XV. Schrör, K. (2011). Pharmacology and cellular/molecular mechanisms of action of aspirin and non-aspirin NSAIDs in colorectal cancer. Best practice & research Clinical gastroenterology, 25(4-5), 473-484.
XVI. La Vecchia, C., Brinton, L. A., & McTiernan, A. (2001). Menopause, hormone replacement therapy and cancer. Maturitas, 39(2), 97-115.
XVII. Bjelakovic, G., Nagorni, A., Nikolova, D., Simonetti, R. G., Bjelakovic, M., & Gluud, C. (2006). Meta‐analysis: antioxidant supplements for primary and secondary prevention of colorectal adenoma. Alimentary pharmacology & therapeutics, 24(2), 281-291.
XVIII. Green, J., Czanner, G., Reeves, G., Watson, J., Wise, L., & Beral, V. (2010). Oral bisphosphonates and risk of cancer of oesophagus, stomach, and colorectum: case-control analysis within a UK primary care cohort. Bmj, 341.
XIX. Ozawa, T., Hashiguchi, Y., Yagi, T., Fukushima, Y., Shimada, R., Hayama, T., ... & Matsuda, K. (2019). Angiotensin I-converting enzyme inhibitors/angiotensin II receptor blockers may reduce tumor recurrence in left-sided and early colorectal cancers. International Journal of Colorectal Disease, 34(10), 1731-1739.